BEDFORD, Mass., Nov. 6, 2025 /PRNewswire/ -- iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial results for the third quarter ended September 27, 2025.
"Our third-quarter revenue fell well below our internal expectations due to continuing market headwinds, ongoing production delays, and unforeseen shipping disruptions," said Gary Cohen, iRobot CEO. "This shortfall increased cash usage and pressured profitability, as we were unable to fully leverage our fixed cost base."
Third Quarter 2025 Financial Results ( in millions, except per share amounts and percentages)
|
| Q3 2025 | Q3 2024 |
| Revenue | $145.8 | $193.4 |
| GAAP Gross Margin | 31.0 % | 32.2 % |
| Non-GAAP Gross Margin | 31.2 % | 32.4 % |
| GAAP Operating Expenses | $62.9 | $55.1 |
| Non-GAAP Operating Expenses | $55.4 | $47.7 |
| GAAP Operating (Loss) Income | ($17.7) | $7.3 |
| Non-GAAP Operating (Loss) Income | ($9.9) | $15.1 |
| GAAP Net Loss Per Share | ($0.62) | ($0.21) |
| Non-GAAP Net (Loss) Income Per Share | ($0.23) | $0.03 |
Balance Sheet and Operational Highlights
- As of September 27, 2025, the Company's cash and cash equivalents totaled $24.8 million, compared with $40.6 million as of June 28, 2025. As of September 27, 2025, the Company had an additional $5.0 million in restricted cash, which was fully drawn on September 30, 2025. At this time, Company has no sources upon which it can draw for additional capital.
- As of September 27, 2025, the Company's inventory totaled $140.9 million, compared with $149.2 million in the third quarter of 2024.
- In the third quarter of 2025, revenue declined 33% in the U.S., declined 13% in EMEA and declined 9% in Japan over the prior-year period. Excluding the foreign currency impact, EMEA revenue declined 14% while Japan remained flat over the prior-year period.
- Revenue from mid-tier robots (with an MSRP between $300 and $499) and premium robots (with an MSRP of $500 or more) represented 74% of total robot sales in the third quarter of 2025 versus 79% from the same period last year.
Strategic Review Process
The Company refers investors to its Form 10-Q filed with the SEC on November 6, 2025 for details regarding its previously announced strategic review process.
About iRobot
iRobot is a global consumer robot company that designs and builds thoughtful robots and intelligent home innovations that make life better. iRobot introduced the first Roomba robot vacuum in 2002. Today, iRobot is a global enterprise that has sold millions of robots worldwide. iRobot's product portfolio features technologies and advanced concepts in cleaning, mapping and navigation. Working from this portfolio, iRobot engineers are building robots and smart home devices to help consumers make their homes easier to maintain and healthier places to live. For more information about iRobot, please visit www.irobot.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which relate to, among other things: the Company's profitability and near-term capital requirements, and the strategic review process. These forward-looking statements are based on the Company's current expectations, estimates and projections about its business and industry, all of which are subject to change. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "could," "seek," "see," "will," "may," "would," "might," "potentially," "estimate," "continue," "expect," "target," similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond the Company's control, and are not guarantees of future results. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: (i) the Company's ability to obtain new capital in the near term, if at all; (ii) the Company's ability to realize the benefits of its operational restructuring; (iii) the impact of various global conflicts on the Company's business and general economic conditions; (iv) the Company's ability to implement its business strategy; (v) the risk that disruptions from the Company's operational restructuring will harm its business, including current plans and operations; (vi) the ability of the Company to retain and hire skilled personnel; (vii) loss of any key employee; (viii) failure of the Company's primary contract manufacturer to meet the Company's requirements; (ix) legislative, regulatory and economic developments affecting the Company's business; (x) general economic and market developments and conditions; (xi) the evolving legal, regulatory and tax regimes under which the Company operates; (xii) potential business uncertainty, including changes to existing business relationships that could affect the Company's financial performance; (xiii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities; (xiv) current supply chain challenges; (xv) the financial strength of the Company's customers and retailers; (xvi) the impact of any applicable tariffs on goods imported into the United States; (xvii) competition; (xviii) cybersecurity risks; (xix) failure to obtain additional waivers from the Company's lenders of the Company's obligation to comply with certain covenants under the Company's credit agreement; and (xx) the results and impact of the Board's strategic review of alternatives for the business, as well as the Company's response to any of the aforementioned factors. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption "Risk Factors" in the Company's most recent annual and quarterly reports filed with the SEC and any subsequent reports on Form 10-K, Form 10-Q or Form 8-K filed from time to time and available at www.sec.gov. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability and similar risks, any of which could have a material adverse effect on the Company's financial condition, results of operations, or liquidity. The forward-looking statements included herein are made only as of the date hereof. The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
| iRobot Corporation | |||||||
| Consolidated Statements of Operations | |||||||
| (in thousands, except per share amounts) | |||||||
| (unaudited) | |||||||
| | | | | | | | |
| | | | | | | | |
| | For the three months ended | | For the nine months ended | ||||
| | September 27, 2025 | | September 28, 2024 | | September 27, 2025 | | September 28, 2024 |
| | | | | | | | |
| Revenue | $ 145,832 | | $ 193,435 | | $ 374,959 | | $ 509,811 |
| Cost of revenue: | | | | | | | |
| Cost of product revenue | 100,580 | | 131,058 | | 269,437 | | 383,865 |
| Restructuring and other | - | | - | | 1,658 | | - |
| Total cost of revenue | 100,580 | | 131,058 | | 271,095 | | 383,865 |
| | | | | | | | |
| Gross profit | 45,252 | | 62,377 | | 103,864 | | 125,946 |
| | | | | | | | |
| Operating expenses: | | | | | | | |
| Research and development | 13,094 | | 19,630 | | 41,547 | | 76,739 |
| Selling and marketing | 29,256 | | 29,270 | | 94,310 | | 98,966 |
| General and administrative | 20,346 | | 3,232 | | 60,430 | | (33,552) |
| Restructuring and other | 81 | | 1,922 | | 7,287 | | 24,298 |
| Amortization of acquired intangible assets | 146 | | 1,066 | | 427 | | 1,405 |
| Total operating expenses | 62,923 | | 55,120 | | 204,001 | | 167,856 |
| | | | | | | | |
| Operating (loss) income | (17,671) | | 7,257 | | (100,137) | | (41,910) |
| | | | | | | | |
| Other expense, net | (711) | | (12,548) | | (28,391) | | (24,583) |
| | | | | | | | |
| Loss before income taxes | (18,382) | | (5,291) | | (128,528) | | (66,493) |
| Income tax expense | 3,144 | | 1,080 | | 3,079 | | 1,917 |
| Net loss | $ (21,526) | | $ (6,371) | | $ (131,607) | | $ (68,410) |
| | | | | | | | |
| Net loss per share: | | | | | | | |
| Basic | $ (0.62) | | $ (0.21) | | $ (3.97) | | $ (2.34) |
| Diluted | $ (0.62) | | $ (0.21) | | $ (3.97) | | $ (2.34) |
| | | | | | | | |
| Number of shares used in per share calculations: | | | | | | | |
| Basic | 34,866 | | 30,348 | | 33,128 | | 29,276 |
| Diluted | 34,866 | | 30,348 | | 33,128 | | 29,276 |
| | | | | | | | |
| Stock-based compensation included in above figures: | | | | | |||
| Cost of revenue | $ 277 | | $ 387 | | $ 820 | | $ 1,486 |
| Research and development | 554 | | 1,296 | | 2,221 | | 4,994 |
| Selling and marketing | 717 | | 903 | | 2,490 | | 3,403 |
| General and administrative | 2,306 | | 2,894 | | 7,399 | | 8,054 |
| Total | $ 3,854 | | $ 5,480 | | $ 12,930 | | $ 17,937 |
| iRobot Corporation | |||
| Condensed Consolidated Balance Sheets | |||
| (unaudited, in thousands) | |||
| | | | |
| | September 27, 2025 | | December 28, 2024 |
| | | | |
| Assets | | | |
| | | | |
| Cash and cash equivalents | $ 24,828 | | $ 134,303 |
| Restricted cash | 5,000 | | 1,259 |
| Accounts receivable, net | 56,813 | | 49,865 |
| Inventory | 140,910 | | 76,029 |
| Other current assets | 20,919 | | 27,046 |
| Total current assets | 248,470 | | 288,502 |
| Property and equipment, net | 9,850 | | 15,835 |
| Operating lease right-of-use assets | 12,259 | | 14,322 |
| Deferred tax assets | 10,162 | | 9,817 |
| Goodwill | 182,450 | | 167,288 |
| Intangible assets, net | 3,086 | | 3,212 |
| Other assets | 15,296 | | 17,161 |
| Total assets | $ 481,573 | | $ 516,137 |
| | | | |
| Liabilities and stockholders' (deficit) equity | | | |
| | | | |
| Accounts payable | $ 197,047 | | $ 106,367 |
| Accrued expenses | 70,606 | | 100,597 |
| Deferred revenue and customer advances | 7,931 | | 11,280 |
| Term loan | 205,292 | | - |
| Total current liabilities | 480,876 | | 218,244 |
| Term loan | - | | 200,604 |
| Operating lease liabilities | 17,762 | | 21,598 |
| Other long-term liabilities | 9,820 | | 14,452 |
| Total long-term liabilities | 27,582 | | 236,654 |
| Total liabilities | 508,458 | | 454,898 |
| Stockholders' (deficit) equity | (26,885) | | 61,239 |
| Total liabilities and stockholders' (deficit) equity | $ 481,573 | | $ 516,137 |
| iRobot Corporation | |||
| Consolidated Statements of Cash Flows | |||
| (unaudited, in thousands) | |||
| | | | |
| | | | |
| | For the nine months ended | ||
| | September 27, 2025 | | September 28, 2024 |
| Cash flows from operating activities: | | | |
| Net loss | $ (131,607) | | $ (68,410) |
| Adjustments to reconcile net loss to net cash used in operating activities: | | | |
| Depreciation and amortization | 5,919 | | 16,912 |
| Loss on equity investment | 1,566 | | 375 |
| Stock-based compensation | 12,930 | | 17,937 |
| Provision for inventory excess and obsolescence | 1,340 | | 11,800 |
| Change in fair value of term loan | (1,079) | | 13,515 |
| Debt issuance costs associated with warrants issued | 16,828 | | - |
| Debt issuance costs expensed under fair value option | - | | 529 |
| Deferred income taxes, net | 4,659 | | (651) |
| Other | 4,600 | | (6,318) |
| Changes in operating assets and liabilities - (use) source | | | |
| Accounts receivable | (4,814) | | (22,073) |
| Inventory | (66,663) | | (10,539) |
| Other assets | 5,815 | | 15,598 |
| Accounts payable | 89,967 | | 16,674 |
| Accrued expenses and other liabilities | (43,664) | | (15,825) |
| Net cash used in operating activities | (104,203) | | (30,476) |
| | | | |
| Cash flows from investing activities: | | | |
| Additions of property and equipment | - | | (118) |
| Purchase of investments | (14) | | (56) |
| Sales and maturities of investments | 594 | | - |
| Net cash provided by (used in) investing activities | 580 | | (174) |
| | | | |
| Cash flows from financing activities: | | | |
| Income tax withholding payment associated with restricted stock vesting | (371) | | (491) |
| Proceeds from issuance of common stock, net of issuance costs | - | | 19,359 |
| Repayment of term loan | (4,000) | | (34,947) |
| Payment of debt issuance costs | - | | (529) |
| Net cash used in financing activities | (4,371) | | (16,608) |
| | | | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,856 | | 1,251 |
| Net decrease in cash, cash equivalents and restricted cash | (106,138) | | (46,007) |
| Cash, cash equivalents and restricted cash, at beginning of period | 137,951 | | 187,887 |
| Cash, cash equivalents and restricted cash, at end of period | $ 31,813 | | $ 141,880 |
| | | | |
| Cash, cash equivalents and restricted cash, at end of period: | | | |
| Cash and cash equivalents | $ 24,828 | | $ 99,447 |
| Restricted cash | 5,000 | | 41,082 |
| Restricted cash, non-current (included in other assets) | 1,985 | | 1,351 |
| Cash, cash equivalents and restricted cash, at end of period | $ 31,813 | | $ 141,880 |
| iRobot Corporation | |||||||
| Supplemental Information | |||||||
| (unaudited) | |||||||
| | | | | | | | |
| | | | | | | | |
| | For the three months ended | | For the nine months ended | ||||
| | September 27, 2025 | | September 28, 2024 | | September 27, 2025 | | September 28, 2024 |
| Revenue by Geographical Region * | | | | | | | |
| United States | $ 70,772 | | $ 105,137 | | $ 168,653 | | $ 258,398 |
| EMEA | 39,733 | | 45,902 | | 105,933 | | 130,884 |
| Japan | 25,138 | | 27,718 | | 76,511 | | 83,254 |
| Other | 10,189 | | 14,678 | | 23,862 | | 37,275 |
| Total | $ 145,832 | | $ 193,435 | | $ 374,959 | | $ 509,811 |
| | | | | | | | |
| Robot Units Shipped * | | | | | | | |
| 2-in-1 | 498 | | 445 | | 1,263 | | 908 |
| Solo and other | 57 | | 287 | | 218 | | 854 |
| Total | 555 | | 732 | | 1,481 | | 1,762 |
| | | | | | | | |
| Revenue by Product Category ** | | | | | | | |
| 2-in-1 | $ 124 | | $ 110 | | $ 289 | | $ 242 |
| Solo and other | 22 | | 83 | | 86 | | 268 |
| Total | $ 146 | | $ 193 | | $ 375 | | $ 510 |
| | | | | | | | |
| Average gross selling prices for robot units | $ 330 | | $ 313 | | $ 311 | | $ 329 |
| | | | | | | | |
| Headcount | 492 | | 661 | | | | |
| | | | | | | | |
| | | | | | | | |
| * in thousands | | | | | | | |
| ** in millions | | | | | | | |
| | | | | | | | |
| Certain numbers may not total due to rounding | | | | | | | |
iRobot Corporation
Explanation of Non-GAAP Measures
In addition to disclosing financial results in accordance with U.S. GAAP, this earnings release contains references to the non-GAAP financial measures described below. We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures.
Our non-GAAP financial measures reflect adjustments based on the following items. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated.
Amortization of Acquired Intangible Assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations as well as any non-cash impairment charges associated with intangible assets in connection with our past acquisitions. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of professional fees associated with mergers, acquisitions and the review of strategic alternatives, including, but not limited to, exploring a potential sale or strategic transaction. During the first quarter of fiscal 2024, the adjustment included the one-time net termination fee received as a result of the termination of the iRobot-Amazon Merger. The occurrence and amount of these costs will vary depending on the timing and size of these transactions. We exclude these charges from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance.
Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards. We exclude this expense as it is a non-cash expense, and we assess our internal operations excluding this expense and believe it facilitates comparisons to the performance of other companies.
Restructuring and Other: Restructuring charges are related to one-time actions associated with realigning resources, enhancing operational productivity and efficiency, or improving our cost structure in support of our strategy. Such actions are not reflective of ongoing operations and include costs primarily associated with severance and related costs, costs associated with early termination of contracts, charges related to paused work unrelated to our core business, costs associated with the Chief Executive Officer transition and other non-recurring costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions. We exclude these items from our non-GAAP measures when evaluating our recent and prospective business performance as such items vary significantly based on the magnitude of the action and do not reflect anticipated future operating costs. In addition, these charges do not necessarily provide meaningful insight into the fundamentals of current or past operations of our business.
Gain/Loss on Strategic Investments: Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments. We exclude these items from our non-GAAP measures because we do not believe they correlate to the performance of our core business and may vary in size based on market conditions and events. We believe that the exclusion of these gains or losses provides investors with a supplemental view of our operational performance.
Debt Issuance Costs: Debt issuance costs include various incremental fees paid to third parties and warrants issued in connection with the issuance or amendment of debt.
Income Tax Adjustments: Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We regularly assess the need to record valuation allowance based on the non-GAAP profitability and other factors. We also exclude certain tax items, including the impact from stock-based compensation windfalls/shortfalls, which are not reflective of income tax expense incurred as a result of current period earnings. We believe disclosure of the income tax provision before the effect of such tax items is important to permit investors' consistent earnings comparison between periods.
| iRobot Corporation | |||||||
| Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals | |||||||
| (in thousands, except per share amounts) | |||||||
| (unaudited) | |||||||
| | | | | | | | |
| | | | | | | ||
| | For the three months ended | | For the nine months ended | ||||
| | September 27, 2025 | | September 28, 2024 | | September 27, 2025 | | September 28, 2024 |
| GAAP Revenue | $ 145,832 | | $ 193,435 | | $ 374,959 | | $ 509,811 |
| | | | | | | | |
| GAAP Gross Profit | $ 45,252 | | $ 62,377 | | $ 103,864 | | $ 125,946 |
| Stock-based compensation | 277 | | 387 | | 820 | | 1,486 |
| Restructuring and other | - | | - | | 1,658 | | - |
| Non-GAAP Gross Profit | $ 45,529 | | $ 62,764 | | $ 106,342 | | $ 127,432 |
| GAAP Gross Margin | 31.0 % | | 32.2 % | | 27.7 % | | 24.7 % |
| Non-GAAP Gross Margin | 31.2 % | | 32.4 % | | 28.4 % | | 25.0 % |
| | | | | | | | |
| GAAP Operating Expenses | $ 62,923 | | $ 55,120 | | $ 204,001 | | $ 167,856 |
| Amortization of acquired intangible assets | (146) | | (1,066) | | (427) | | (1,405) |
| Stock-based compensation | (3,577) | | (5,093) | | (12,110) | | (16,451) |
| Net merger, acquisition and divestiture (expense) income | (3,704) | | 656 | | (9,422) | | 74,813 |
| Restructuring and other | (81) | | (1,922) | | (7,287) | | (24,298) |
| Non-GAAP Operating Expenses | $ 55,415 | | $ 47,695 | | $ 174,755 | | $ 200,515 |
| GAAP Operating Expenses as a % of GAAP Revenue | 43.1 % | | 28.5 % | | 54.4 % | | 32.9 % |
| Non-GAAP Operating Expenses as a % of Non-GAAP Revenue | 38.0 % | | 24.7 % | | 46.6 % | | 39.3 % |
| | | | | | | | |
| GAAP Operating (Loss) Income | $ (17,671) | | $ 7,257 | | $ (100,137) | | $ (41,910) |
| Amortization of acquired intangible assets | 146 | | 1,066 | | 427 | | 1,405 |
| Stock-based compensation | 3,854 | | 5,480 | | 12,930 | | 17,937 |
| Net merger, acquisition and divestiture expense (income) | 3,704 | | (656) | | 9,422 | | (74,813) |
| Restructuring and other | 81 | | 1,922 | | 8,945 | | 24,298 |
| Non-GAAP Operating (Loss) Income | $ (9,886) | | $ 15,069 | | $ (68,413) | | $ (73,083) |
| GAAP Operating Margin | (12.1) % | | 3.8 % | | (26.7) % | | (8.2) % |
| Non-GAAP Operating Margin | (6.8) % | | 7.8 % | | (18.2) % | | (14.3) % |
| | | | | | | | |
| | | | | | | | |
| iRobot Corporation | |||||||
| Supplemental Reconciliation of GAAP Actuals to Non-GAAP Actuals continued | |||||||
| (in thousands, except per share amounts) | |||||||
| (unaudited) | |||||||
| | | | | | | | |
| | | | | | | | |
| | For the three months ended | | For the nine months ended | ||||
| | September 27, 2025 | | September 28, 2024 | | September 27, 2025 | | September 28, 2024 |
| GAAP Income Tax Expense | $ 3,144 | | $ 1,080 | | $ 3,079 | | $ 1,917 |
| Tax effect of non-GAAP adjustments | 43 | | 650 | | 269 | | 1,667 |
| Other tax adjustments | (2,854) | | (203) | | (2,063) | | (811) |
| Non-GAAP Income Tax Expense | $ 333 | | $ 1,527 | | $ 1,285 | | $ 2,773 |
| | | | | | | | |
| GAAP Net Loss | $ (21,526) | | $ (6,371) | | $ (131,607) | | $ (68,410) |
| Amortization of acquired intangible assets | 146 | | 1,066 | | 427 | | 1,405 |
| Stock-based compensation | 3,854 | | 5,480 | | 12,930 | | 17,937 |
| Net merger, acquisition and divestiture expense (income) | 3,704 | | (656) | | 9,422 | | (74,813) |
| Restructuring and other | 81 | | 1,922 | | 8,945 | | 24,298 |
| Loss on strategic investments | 1,960 | | - | | 1,566 | | 375 |
| Debt issuance costs | 944 | | 52 | | 19,580 | | 529 |
| Income tax effect | 2,811 | | (447) | | 1,794 | | (856) |
| Non-GAAP Net (Loss) Income | $ (8,026) | | $ 1,046 | | $ (76,943) | | $ (99,535) |
| | | | | | | | |
| GAAP Net Loss Per Diluted Share | $ (0.62) | | $ (0.21) | | $ (3.97) | | $ (2.34) |
| Amortization of acquired intangible assets | - | | 0.03 | | 0.01 | | 0.05 |
| Stock-based compensation | 0.11 | | 0.18 | | 0.39 | | 0.61 |
| Net merger, acquisition and divestiture expense (income) | 0.11 | | (0.02) | | 0.29 | | (2.55) |
| Restructuring and other | - | | 0.06 | | 0.27 | | 0.83 |
| Loss on strategic investments | 0.06 | | - | | 0.05 | | 0.01 |
| Debt issuance costs | 0.03 | | - | | 0.59 | | 0.02 |
| Income tax effect | 0.08 | | (0.01) | | 0.05 | | (0.03) |
| Non-GAAP Net (Loss) Income Per Diluted Share | $ (0.23) | | $ 0.03 | | $ (2.32) | | $ (3.40) |
| | | | | | | | |
| Number of shares used in diluted per share calculation | 34,866 | | 30,551 | | 33,128 | | 29,276 |
| | | | | | | | |
| Supplemental Information | | | | | | | |
| Days sales outstanding | 36 | | 48 | | | | |
| GAAP Days in inventory | 128 | | 104 | | | | |
| Non-GAAP Days in inventory(1) | 128 | | 104 | | | | |
| | | | | | | | |
| | | | | | | | |
| (1) Non-GAAP Days in inventory is calculated as inventory divided by (Revenue minus Non-GAAP Gross Profit), multiplied by 91 days. | |||||||
SOURCE iRobot Corporation
